When AI designs a drug, who gets the credit?
- Source
- MIT Technology Review - All
- Source link
- https://www.technologyreview.com/2026/08/21/1142627/when-ai-designs-a-drug-who-gets-the-credit
- Published
- 2026-08-21 09:00:00
- Discovered by ProcIntel
- 2026-08-21 09:22:34
- Category
- Procurement Technology & AI
- Geography
- Global
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-08-21 09:22:34
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.